Biotech Stocks Facing FDA Decision In September 2021

1 / 12

The FDA approved 4 *novel drugs in the month of August, bringing the total number of novel drug approvals so far this year to 36.

Skytrofa, to treat short stature due to inadequate secretion of endogenous growth hormone, Korsuva, to treat pruritus associated with chronic kidney disease, Welireg, treat von Hippel-Lindau disease, and Nexviazyme, to treat Pompe disease, are the novel drugs approved in August.

*Novel drugs are new molecular entities (NMEs) having chemical structures that have never been approved before.